On the current debate on lowering LDL cholesterine with ezetimibe

被引：1
|
作者：
Erdmann, E. [1 ]
机构：
[1] Herzzentrum Univ Koln, Klin Kardiol Angiol Pneumol & Internist Intensivm, D-50937 Cologne, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2010年 / 135卷 / 36期
关键词：
LDL cholesterine; Ezetimibe; Simvastatin; Surrogate parameter;
D O I：
10.1055/s-0030-1263304
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1742 / 1742
页数：1
相关论文
共 50 条
  • [21] Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients
    Thongtang, Nuntakorn
    Lin, Jianxin
    Schaefer, Ernst J.
    Lowe, Robert S.
    Tomassini, Joanne E.
    Shah, Arvind K.
    Tershakovec, Andrew M.
    ATHEROSCLEROSIS, 2012, 225 (02) : 388 - 396
  • [22] Ezetimibe 5 and 10 mg for Lowering LDL-C: Potential Billion-Dollar Savings With Improved Tolerability
    Baruch, Lawrence
    Gupta, Bhanu
    Lieberman-Blum, Sharon S.
    Agarwal, Sanjay
    Eng, Calvin
    AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (10): : 637 - 641
  • [23] Comments on the Ezetimibe Debate in Chicago Response
    Brown, W. Virgil
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (04) : 316 - 317
  • [24] Ezetimibe/simvastatin combination reduces LDL cholesterol
    不详
    FORMULARY, 2004, 39 (04) : 199 - 200
  • [25] Ezetimibe in diabetes: more than cholesterol lowering?
    Sarigianni, Maria
    Katsiki, Niki
    Mikhailidis, Dimitri P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (10) : 2517 - 2520
  • [26] Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment
    Simon, JS
    Karnoub, MC
    Devlin, DJ
    Arreaza, MG
    Qiu, P
    Monks, SA
    Severino, ME
    Deutsch, P
    Palmisano, J
    Sachs, AB
    Bayne, ML
    Plump, AS
    Schadt, EE
    GENOMICS, 2005, 86 (06) : 648 - 656
  • [27] Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins
    Sakamoto, Kentaro
    Kawamura, Mitsunobu
    Kohro, Takahide
    Omura, Masao
    Watanabe, Takayuki
    Ashidate, Keiko
    Horiuchi, Toshiyuki
    Hara, Hidehiko
    Sekine, Nobuo
    Chin, Rina
    Tsujino, Motoyoshi
    Hiyoshi, Toru
    Tagami, Motoki
    Tanaka, Akira
    Mori, Yasumichi
    Inazawa, Takeshi
    Hirano, Tsutomu
    Yamazaki, Tsutomu
    Shiba, Teruo
    PLOS ONE, 2015, 10 (09):
  • [28] Utility of Pre-Treatment Non-Cholesterol Sterols in the Prediction of LDL-C Lowering Response to Statins and Ezetimibe
    Williams, Paul T.
    Dansinger, Michael L.
    Superko, H. R.
    Schaefer, Ernst J.
    CIRCULATION, 2019, 140
  • [29] Enhanced LDL-C lowering and attainment is associated with switches from statin monotherapy to ezetimibe/simvastatin (E/S) therapy
    Toth, P. P.
    Foody, J. M.
    Sajjan, S.
    Ramey, D.
    Neff, D.
    Tershakovec, A. M.
    Hu, H.
    Tomassini, J.
    Tunceli, K.
    EUROPEAN HEART JOURNAL, 2010, 31 : 1022 - 1023
  • [30] Beyond lowering LDL cholesterol
    Bayturan, Ozgur
    Utuk, Ozan
    Tuzcu, E. Murat
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2011, 11 (02): : 163 - 167
12345